nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Sorafenib—thyroid cancer	0.32	0.515	CbGbCtD
Eprosartan—ABCC2—Doxorubicin—thyroid cancer	0.194	0.312	CbGbCtD
Eprosartan—CYP2C9—Sorafenib—thyroid cancer	0.108	0.173	CbGbCtD
Eprosartan—Constipation—Vandetanib—thyroid cancer	0.00144	0.00381	CcSEcCtD
Eprosartan—Pain—Vandetanib—thyroid cancer	0.00144	0.00381	CcSEcCtD
Eprosartan—Otitis media—Doxorubicin—thyroid cancer	0.0014	0.0037	CcSEcCtD
Eprosartan—Gingivitis—Doxorubicin—thyroid cancer	0.00139	0.00367	CcSEcCtD
Eprosartan—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00138	0.00364	CcSEcCtD
Eprosartan—Glycosuria—Doxorubicin—thyroid cancer	0.00134	0.00356	CcSEcCtD
Eprosartan—Muscle spasms—Sorafenib—thyroid cancer	0.00134	0.00354	CcSEcCtD
Eprosartan—Rigors—Doxorubicin—thyroid cancer	0.00133	0.00353	CcSEcCtD
Eprosartan—Abdominal pain—Vandetanib—thyroid cancer	0.00133	0.00352	CcSEcCtD
Eprosartan—Body temperature increased—Vandetanib—thyroid cancer	0.00133	0.00352	CcSEcCtD
Eprosartan—Viral infection—Epirubicin—thyroid cancer	0.0013	0.00345	CcSEcCtD
Eprosartan—Arthropathy—Epirubicin—thyroid cancer	0.00129	0.00342	CcSEcCtD
Eprosartan—Herpes simplex—Epirubicin—thyroid cancer	0.00128	0.00338	CcSEcCtD
Eprosartan—Angioedema—Sorafenib—thyroid cancer	0.00127	0.00337	CcSEcCtD
Eprosartan—Syncope—Sorafenib—thyroid cancer	0.00125	0.0033	CcSEcCtD
Eprosartan—Bone pain—Epirubicin—thyroid cancer	0.00123	0.00325	CcSEcCtD
Eprosartan—Loss of consciousness—Sorafenib—thyroid cancer	0.00122	0.00324	CcSEcCtD
Eprosartan—Cough—Sorafenib—thyroid cancer	0.00121	0.00321	CcSEcCtD
Eprosartan—Asthenia—Vandetanib—thyroid cancer	0.00121	0.0032	CcSEcCtD
Eprosartan—Viral infection—Doxorubicin—thyroid cancer	0.0012	0.00319	CcSEcCtD
Eprosartan—Arthropathy—Doxorubicin—thyroid cancer	0.0012	0.00317	CcSEcCtD
Eprosartan—Pruritus—Vandetanib—thyroid cancer	0.00119	0.00315	CcSEcCtD
Eprosartan—Myalgia—Sorafenib—thyroid cancer	0.00118	0.00314	CcSEcCtD
Eprosartan—Arthralgia—Sorafenib—thyroid cancer	0.00118	0.00314	CcSEcCtD
Eprosartan—Herpes simplex—Doxorubicin—thyroid cancer	0.00118	0.00313	CcSEcCtD
Eprosartan—Dry mouth—Sorafenib—thyroid cancer	0.00116	0.00307	CcSEcCtD
Eprosartan—Diarrhoea—Vandetanib—thyroid cancer	0.00115	0.00305	CcSEcCtD
Eprosartan—Cystitis noninfective—Epirubicin—thyroid cancer	0.00115	0.00304	CcSEcCtD
Eprosartan—Influenza like illness—Epirubicin—thyroid cancer	0.00114	0.00302	CcSEcCtD
Eprosartan—Bone pain—Doxorubicin—thyroid cancer	0.00114	0.00301	CcSEcCtD
Eprosartan—Cystitis—Epirubicin—thyroid cancer	0.00114	0.00301	CcSEcCtD
Eprosartan—Shock—Sorafenib—thyroid cancer	0.00112	0.00296	CcSEcCtD
Eprosartan—Dizziness—Vandetanib—thyroid cancer	0.00111	0.00295	CcSEcCtD
Eprosartan—Thrombocytopenia—Sorafenib—thyroid cancer	0.00111	0.00294	CcSEcCtD
Eprosartan—Anorexia—Sorafenib—thyroid cancer	0.00108	0.00287	CcSEcCtD
Eprosartan—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00108	0.00286	CcSEcCtD
Eprosartan—Oesophagitis—Epirubicin—thyroid cancer	0.00107	0.00285	CcSEcCtD
Eprosartan—Vomiting—Vandetanib—thyroid cancer	0.00107	0.00283	CcSEcCtD
Eprosartan—Rash maculo-papular—Epirubicin—thyroid cancer	0.00107	0.00283	CcSEcCtD
Eprosartan—Bladder pain—Epirubicin—thyroid cancer	0.00106	0.00282	CcSEcCtD
Eprosartan—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00106	0.00281	CcSEcCtD
Eprosartan—Rash—Vandetanib—thyroid cancer	0.00106	0.00281	CcSEcCtD
Eprosartan—Dermatitis—Vandetanib—thyroid cancer	0.00106	0.00281	CcSEcCtD
Eprosartan—Influenza like illness—Doxorubicin—thyroid cancer	0.00106	0.0028	CcSEcCtD
Eprosartan—Headache—Vandetanib—thyroid cancer	0.00105	0.00279	CcSEcCtD
Eprosartan—Cystitis—Doxorubicin—thyroid cancer	0.00105	0.00278	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00103	0.00274	CcSEcCtD
Eprosartan—Abnormal vision—Epirubicin—thyroid cancer	0.00103	0.00272	CcSEcCtD
Eprosartan—Dyspnoea—Sorafenib—thyroid cancer	0.00101	0.00268	CcSEcCtD
Eprosartan—Nausea—Vandetanib—thyroid cancer	0.001	0.00265	CcSEcCtD
Eprosartan—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.001	0.00265	CcSEcCtD
Eprosartan—Dyspepsia—Sorafenib—thyroid cancer	0.000999	0.00265	CcSEcCtD
Eprosartan—Oesophagitis—Doxorubicin—thyroid cancer	0.000994	0.00263	CcSEcCtD
Eprosartan—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000989	0.00262	CcSEcCtD
Eprosartan—Decreased appetite—Sorafenib—thyroid cancer	0.000987	0.00261	CcSEcCtD
Eprosartan—Bladder pain—Doxorubicin—thyroid cancer	0.000984	0.00261	CcSEcCtD
Eprosartan—Diabetes mellitus—Epirubicin—thyroid cancer	0.000982	0.0026	CcSEcCtD
Eprosartan—Fatigue—Sorafenib—thyroid cancer	0.000979	0.00259	CcSEcCtD
Eprosartan—Pain—Sorafenib—thyroid cancer	0.000971	0.00257	CcSEcCtD
Eprosartan—Constipation—Sorafenib—thyroid cancer	0.000971	0.00257	CcSEcCtD
Eprosartan—Vascular purpura—Epirubicin—thyroid cancer	0.000954	0.00253	CcSEcCtD
Eprosartan—Eczema—Epirubicin—thyroid cancer	0.00095	0.00252	CcSEcCtD
Eprosartan—Abnormal vision—Doxorubicin—thyroid cancer	0.000949	0.00251	CcSEcCtD
Eprosartan—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000928	0.00246	CcSEcCtD
Eprosartan—Hot flush—Epirubicin—thyroid cancer	0.000913	0.00242	CcSEcCtD
Eprosartan—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000908	0.0024	CcSEcCtD
Eprosartan—Menopausal symptoms—Epirubicin—thyroid cancer	0.000905	0.0024	CcSEcCtD
Eprosartan—Urticaria—Sorafenib—thyroid cancer	0.000902	0.00239	CcSEcCtD
Eprosartan—Abdominal pain—Sorafenib—thyroid cancer	0.000898	0.00238	CcSEcCtD
Eprosartan—Body temperature increased—Sorafenib—thyroid cancer	0.000898	0.00238	CcSEcCtD
Eprosartan—Purpura—Epirubicin—thyroid cancer	0.000886	0.00235	CcSEcCtD
Eprosartan—Vascular purpura—Doxorubicin—thyroid cancer	0.000883	0.00234	CcSEcCtD
Eprosartan—Eczema—Doxorubicin—thyroid cancer	0.000879	0.00233	CcSEcCtD
Eprosartan—Cardiac failure—Epirubicin—thyroid cancer	0.000875	0.00232	CcSEcCtD
Eprosartan—Hyponatraemia—Epirubicin—thyroid cancer	0.000857	0.00227	CcSEcCtD
Eprosartan—Osteoarthritis—Epirubicin—thyroid cancer	0.000854	0.00226	CcSEcCtD
Eprosartan—Hot flush—Doxorubicin—thyroid cancer	0.000844	0.00224	CcSEcCtD
Eprosartan—Migraine—Epirubicin—thyroid cancer	0.00084	0.00223	CcSEcCtD
Eprosartan—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000837	0.00222	CcSEcCtD
Eprosartan—Hypersensitivity—Sorafenib—thyroid cancer	0.000837	0.00221	CcSEcCtD
Eprosartan—Face oedema—Epirubicin—thyroid cancer	0.000824	0.00218	CcSEcCtD
Eprosartan—Purpura—Doxorubicin—thyroid cancer	0.00082	0.00217	CcSEcCtD
Eprosartan—Asthenia—Sorafenib—thyroid cancer	0.000815	0.00216	CcSEcCtD
Eprosartan—Cardiac failure—Doxorubicin—thyroid cancer	0.000809	0.00214	CcSEcCtD
Eprosartan—Pruritus—Sorafenib—thyroid cancer	0.000803	0.00213	CcSEcCtD
Eprosartan—Ataxia—Epirubicin—thyroid cancer	0.000803	0.00213	CcSEcCtD
Eprosartan—Blood creatinine increased—Epirubicin—thyroid cancer	0.0008	0.00212	CcSEcCtD
Eprosartan—Hyponatraemia—Doxorubicin—thyroid cancer	0.000793	0.0021	CcSEcCtD
Eprosartan—Osteoarthritis—Doxorubicin—thyroid cancer	0.00079	0.00209	CcSEcCtD
Eprosartan—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00078	0.00206	CcSEcCtD
Eprosartan—Migraine—Doxorubicin—thyroid cancer	0.000778	0.00206	CcSEcCtD
Eprosartan—Hypokalaemia—Epirubicin—thyroid cancer	0.000777	0.00206	CcSEcCtD
Eprosartan—Diarrhoea—Sorafenib—thyroid cancer	0.000777	0.00206	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000769	0.00204	CcSEcCtD
Eprosartan—Face oedema—Doxorubicin—thyroid cancer	0.000763	0.00202	CcSEcCtD
Eprosartan—Gastritis—Epirubicin—thyroid cancer	0.000756	0.002	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000753	0.00199	CcSEcCtD
Eprosartan—Muscular weakness—Epirubicin—thyroid cancer	0.000753	0.00199	CcSEcCtD
Eprosartan—Dizziness—Sorafenib—thyroid cancer	0.000751	0.00199	CcSEcCtD
Eprosartan—Ataxia—Doxorubicin—thyroid cancer	0.000743	0.00197	CcSEcCtD
Eprosartan—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00074	0.00196	CcSEcCtD
Eprosartan—Asthma—Epirubicin—thyroid cancer	0.000738	0.00195	CcSEcCtD
Eprosartan—Vomiting—Sorafenib—thyroid cancer	0.000722	0.00191	CcSEcCtD
Eprosartan—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000721	0.00191	CcSEcCtD
Eprosartan—Hypokalaemia—Doxorubicin—thyroid cancer	0.000719	0.0019	CcSEcCtD
Eprosartan—Angina pectoris—Epirubicin—thyroid cancer	0.000719	0.0019	CcSEcCtD
Eprosartan—Rash—Sorafenib—thyroid cancer	0.000716	0.0019	CcSEcCtD
Eprosartan—Dermatitis—Sorafenib—thyroid cancer	0.000715	0.00189	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000711	0.00188	CcSEcCtD
Eprosartan—Headache—Sorafenib—thyroid cancer	0.000711	0.00188	CcSEcCtD
Eprosartan—Bronchitis—Epirubicin—thyroid cancer	0.00071	0.00188	CcSEcCtD
Eprosartan—Gastritis—Doxorubicin—thyroid cancer	0.000699	0.00185	CcSEcCtD
Eprosartan—Muscular weakness—Doxorubicin—thyroid cancer	0.000697	0.00184	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000697	0.00184	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000686	0.00182	CcSEcCtD
Eprosartan—Asthma—Doxorubicin—thyroid cancer	0.000683	0.00181	CcSEcCtD
Eprosartan—Pollakiuria—Epirubicin—thyroid cancer	0.000682	0.0018	CcSEcCtD
Eprosartan—Nausea—Sorafenib—thyroid cancer	0.000674	0.00179	CcSEcCtD
Eprosartan—Hyperglycaemia—Epirubicin—thyroid cancer	0.000666	0.00176	CcSEcCtD
Eprosartan—Angina pectoris—Doxorubicin—thyroid cancer	0.000665	0.00176	CcSEcCtD
Eprosartan—Bronchitis—Doxorubicin—thyroid cancer	0.000657	0.00174	CcSEcCtD
Eprosartan—Renal failure—Epirubicin—thyroid cancer	0.000647	0.00171	CcSEcCtD
Eprosartan—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000645	0.00171	CcSEcCtD
Eprosartan—Conjunctivitis—Epirubicin—thyroid cancer	0.00064	0.00169	CcSEcCtD
Eprosartan—Urinary tract infection—Epirubicin—thyroid cancer	0.00064	0.00169	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000635	0.00168	CcSEcCtD
Eprosartan—Pollakiuria—Doxorubicin—thyroid cancer	0.000631	0.00167	CcSEcCtD
Eprosartan—Haematuria—Epirubicin—thyroid cancer	0.000627	0.00166	CcSEcCtD
Eprosartan—Epistaxis—Epirubicin—thyroid cancer	0.000621	0.00164	CcSEcCtD
Eprosartan—Sinusitis—Epirubicin—thyroid cancer	0.000617	0.00163	CcSEcCtD
Eprosartan—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000616	0.00163	CcSEcCtD
Eprosartan—Bradycardia—Epirubicin—thyroid cancer	0.000601	0.00159	CcSEcCtD
Eprosartan—Renal failure—Doxorubicin—thyroid cancer	0.000598	0.00158	CcSEcCtD
Eprosartan—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000597	0.00158	CcSEcCtD
Eprosartan—Rhinitis—Epirubicin—thyroid cancer	0.000592	0.00157	CcSEcCtD
Eprosartan—Conjunctivitis—Doxorubicin—thyroid cancer	0.000592	0.00157	CcSEcCtD
Eprosartan—Urinary tract infection—Doxorubicin—thyroid cancer	0.000592	0.00157	CcSEcCtD
Eprosartan—Pharyngitis—Epirubicin—thyroid cancer	0.000586	0.00155	CcSEcCtD
Eprosartan—Oedema peripheral—Epirubicin—thyroid cancer	0.000582	0.00154	CcSEcCtD
Eprosartan—Haematuria—Doxorubicin—thyroid cancer	0.00058	0.00154	CcSEcCtD
Eprosartan—Epistaxis—Doxorubicin—thyroid cancer	0.000574	0.00152	CcSEcCtD
Eprosartan—Sinusitis—Doxorubicin—thyroid cancer	0.000571	0.00151	CcSEcCtD
Eprosartan—Visual impairment—Epirubicin—thyroid cancer	0.000569	0.00151	CcSEcCtD
Eprosartan—Bradycardia—Doxorubicin—thyroid cancer	0.000556	0.00147	CcSEcCtD
Eprosartan—Tinnitus—Epirubicin—thyroid cancer	0.000551	0.00146	CcSEcCtD
Eprosartan—Rhinitis—Doxorubicin—thyroid cancer	0.000548	0.00145	CcSEcCtD
Eprosartan—Pharyngitis—Doxorubicin—thyroid cancer	0.000542	0.00144	CcSEcCtD
Eprosartan—Oedema peripheral—Doxorubicin—thyroid cancer	0.000538	0.00143	CcSEcCtD
Eprosartan—Chills—Epirubicin—thyroid cancer	0.00053	0.0014	CcSEcCtD
Eprosartan—Visual impairment—Doxorubicin—thyroid cancer	0.000527	0.00139	CcSEcCtD
Eprosartan—Tinnitus—Doxorubicin—thyroid cancer	0.00051	0.00135	CcSEcCtD
Eprosartan—Flatulence—Epirubicin—thyroid cancer	0.000507	0.00134	CcSEcCtD
Eprosartan—Tension—Epirubicin—thyroid cancer	0.000505	0.00134	CcSEcCtD
Eprosartan—Nervousness—Epirubicin—thyroid cancer	0.000499	0.00132	CcSEcCtD
Eprosartan—Back pain—Epirubicin—thyroid cancer	0.000497	0.00132	CcSEcCtD
Eprosartan—Muscle spasms—Epirubicin—thyroid cancer	0.000494	0.00131	CcSEcCtD
Eprosartan—Chills—Doxorubicin—thyroid cancer	0.00049	0.0013	CcSEcCtD
Eprosartan—Ill-defined disorder—Epirubicin—thyroid cancer	0.000477	0.00126	CcSEcCtD
Eprosartan—Flatulence—Doxorubicin—thyroid cancer	0.000469	0.00124	CcSEcCtD
Eprosartan—Tension—Doxorubicin—thyroid cancer	0.000467	0.00124	CcSEcCtD
Eprosartan—Malaise—Epirubicin—thyroid cancer	0.000464	0.00123	CcSEcCtD
Eprosartan—Nervousness—Doxorubicin—thyroid cancer	0.000462	0.00122	CcSEcCtD
Eprosartan—Vertigo—Epirubicin—thyroid cancer	0.000462	0.00122	CcSEcCtD
Eprosartan—Syncope—Epirubicin—thyroid cancer	0.000461	0.00122	CcSEcCtD
Eprosartan—Back pain—Doxorubicin—thyroid cancer	0.00046	0.00122	CcSEcCtD
Eprosartan—Muscle spasms—Doxorubicin—thyroid cancer	0.000457	0.00121	CcSEcCtD
Eprosartan—Palpitations—Epirubicin—thyroid cancer	0.000454	0.0012	CcSEcCtD
Eprosartan—Loss of consciousness—Epirubicin—thyroid cancer	0.000452	0.0012	CcSEcCtD
Eprosartan—Cough—Epirubicin—thyroid cancer	0.000449	0.00119	CcSEcCtD
Eprosartan—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000441	0.00117	CcSEcCtD
Eprosartan—Myalgia—Epirubicin—thyroid cancer	0.000438	0.00116	CcSEcCtD
Eprosartan—Chest pain—Epirubicin—thyroid cancer	0.000438	0.00116	CcSEcCtD
Eprosartan—Arthralgia—Epirubicin—thyroid cancer	0.000438	0.00116	CcSEcCtD
Eprosartan—Anxiety—Epirubicin—thyroid cancer	0.000436	0.00115	CcSEcCtD
Eprosartan—Discomfort—Epirubicin—thyroid cancer	0.000432	0.00115	CcSEcCtD
Eprosartan—Malaise—Doxorubicin—thyroid cancer	0.000429	0.00114	CcSEcCtD
Eprosartan—Dry mouth—Epirubicin—thyroid cancer	0.000428	0.00113	CcSEcCtD
Eprosartan—Vertigo—Doxorubicin—thyroid cancer	0.000427	0.00113	CcSEcCtD
Eprosartan—Syncope—Doxorubicin—thyroid cancer	0.000427	0.00113	CcSEcCtD
Eprosartan—Palpitations—Doxorubicin—thyroid cancer	0.00042	0.00111	CcSEcCtD
Eprosartan—Loss of consciousness—Doxorubicin—thyroid cancer	0.000418	0.00111	CcSEcCtD
Eprosartan—Cough—Doxorubicin—thyroid cancer	0.000415	0.0011	CcSEcCtD
Eprosartan—Shock—Epirubicin—thyroid cancer	0.000413	0.00109	CcSEcCtD
Eprosartan—Thrombocytopenia—Epirubicin—thyroid cancer	0.000411	0.00109	CcSEcCtD
Eprosartan—Tachycardia—Epirubicin—thyroid cancer	0.00041	0.00108	CcSEcCtD
Eprosartan—Hyperhidrosis—Epirubicin—thyroid cancer	0.000406	0.00107	CcSEcCtD
Eprosartan—Myalgia—Doxorubicin—thyroid cancer	0.000405	0.00107	CcSEcCtD
Eprosartan—Arthralgia—Doxorubicin—thyroid cancer	0.000405	0.00107	CcSEcCtD
Eprosartan—Chest pain—Doxorubicin—thyroid cancer	0.000405	0.00107	CcSEcCtD
Eprosartan—Anxiety—Doxorubicin—thyroid cancer	0.000404	0.00107	CcSEcCtD
Eprosartan—Discomfort—Doxorubicin—thyroid cancer	0.0004	0.00106	CcSEcCtD
Eprosartan—Anorexia—Epirubicin—thyroid cancer	0.0004	0.00106	CcSEcCtD
Eprosartan—Dry mouth—Doxorubicin—thyroid cancer	0.000396	0.00105	CcSEcCtD
Eprosartan—Hypotension—Epirubicin—thyroid cancer	0.000392	0.00104	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000382	0.00101	CcSEcCtD
Eprosartan—Shock—Doxorubicin—thyroid cancer	0.000382	0.00101	CcSEcCtD
Eprosartan—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00038	0.00101	CcSEcCtD
Eprosartan—Insomnia—Epirubicin—thyroid cancer	0.00038	0.001	CcSEcCtD
Eprosartan—Tachycardia—Doxorubicin—thyroid cancer	0.000379	0.001	CcSEcCtD
Eprosartan—Paraesthesia—Epirubicin—thyroid cancer	0.000377	0.000998	CcSEcCtD
Eprosartan—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000375	0.000994	CcSEcCtD
Eprosartan—Dyspnoea—Epirubicin—thyroid cancer	0.000374	0.000991	CcSEcCtD
Eprosartan—Somnolence—Epirubicin—thyroid cancer	0.000373	0.000988	CcSEcCtD
Eprosartan—Anorexia—Doxorubicin—thyroid cancer	0.00037	0.00098	CcSEcCtD
Eprosartan—Dyspepsia—Epirubicin—thyroid cancer	0.000369	0.000978	CcSEcCtD
Eprosartan—Decreased appetite—Epirubicin—thyroid cancer	0.000365	0.000966	CcSEcCtD
Eprosartan—Hypotension—Doxorubicin—thyroid cancer	0.000363	0.000961	CcSEcCtD
Eprosartan—Fatigue—Epirubicin—thyroid cancer	0.000362	0.000958	CcSEcCtD
Eprosartan—Constipation—Epirubicin—thyroid cancer	0.000359	0.00095	CcSEcCtD
Eprosartan—Pain—Epirubicin—thyroid cancer	0.000359	0.00095	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000354	0.000937	CcSEcCtD
Eprosartan—Insomnia—Doxorubicin—thyroid cancer	0.000351	0.00093	CcSEcCtD
Eprosartan—Paraesthesia—Doxorubicin—thyroid cancer	0.000349	0.000923	CcSEcCtD
Eprosartan—Dyspnoea—Doxorubicin—thyroid cancer	0.000346	0.000917	CcSEcCtD
Eprosartan—Feeling abnormal—Epirubicin—thyroid cancer	0.000346	0.000916	CcSEcCtD
Eprosartan—Somnolence—Doxorubicin—thyroid cancer	0.000345	0.000914	CcSEcCtD
Eprosartan—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000343	0.000909	CcSEcCtD
Eprosartan—Dyspepsia—Doxorubicin—thyroid cancer	0.000342	0.000905	CcSEcCtD
Eprosartan—Decreased appetite—Doxorubicin—thyroid cancer	0.000338	0.000894	CcSEcCtD
Eprosartan—Fatigue—Doxorubicin—thyroid cancer	0.000335	0.000886	CcSEcCtD
Eprosartan—Urticaria—Epirubicin—thyroid cancer	0.000333	0.000883	CcSEcCtD
Eprosartan—Pain—Doxorubicin—thyroid cancer	0.000332	0.000879	CcSEcCtD
Eprosartan—Constipation—Doxorubicin—thyroid cancer	0.000332	0.000879	CcSEcCtD
Eprosartan—Abdominal pain—Epirubicin—thyroid cancer	0.000332	0.000878	CcSEcCtD
Eprosartan—Body temperature increased—Epirubicin—thyroid cancer	0.000332	0.000878	CcSEcCtD
Eprosartan—Feeling abnormal—Doxorubicin—thyroid cancer	0.00032	0.000847	CcSEcCtD
Eprosartan—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000317	0.000841	CcSEcCtD
Eprosartan—Hypersensitivity—Epirubicin—thyroid cancer	0.000309	0.000819	CcSEcCtD
Eprosartan—Urticaria—Doxorubicin—thyroid cancer	0.000308	0.000817	CcSEcCtD
Eprosartan—Body temperature increased—Doxorubicin—thyroid cancer	0.000307	0.000813	CcSEcCtD
Eprosartan—Abdominal pain—Doxorubicin—thyroid cancer	0.000307	0.000813	CcSEcCtD
Eprosartan—Asthenia—Epirubicin—thyroid cancer	0.000301	0.000797	CcSEcCtD
Eprosartan—Pruritus—Epirubicin—thyroid cancer	0.000297	0.000786	CcSEcCtD
Eprosartan—Diarrhoea—Epirubicin—thyroid cancer	0.000287	0.00076	CcSEcCtD
Eprosartan—Hypersensitivity—Doxorubicin—thyroid cancer	0.000286	0.000757	CcSEcCtD
Eprosartan—Asthenia—Doxorubicin—thyroid cancer	0.000279	0.000738	CcSEcCtD
Eprosartan—Dizziness—Epirubicin—thyroid cancer	0.000277	0.000735	CcSEcCtD
Eprosartan—Pruritus—Doxorubicin—thyroid cancer	0.000275	0.000727	CcSEcCtD
Eprosartan—Vomiting—Epirubicin—thyroid cancer	0.000267	0.000706	CcSEcCtD
Eprosartan—Diarrhoea—Doxorubicin—thyroid cancer	0.000266	0.000703	CcSEcCtD
Eprosartan—Rash—Epirubicin—thyroid cancer	0.000265	0.000701	CcSEcCtD
Eprosartan—Dermatitis—Epirubicin—thyroid cancer	0.000264	0.0007	CcSEcCtD
Eprosartan—Headache—Epirubicin—thyroid cancer	0.000263	0.000696	CcSEcCtD
Eprosartan—Dizziness—Doxorubicin—thyroid cancer	0.000257	0.00068	CcSEcCtD
Eprosartan—Nausea—Epirubicin—thyroid cancer	0.000249	0.00066	CcSEcCtD
Eprosartan—Vomiting—Doxorubicin—thyroid cancer	0.000247	0.000654	CcSEcCtD
Eprosartan—Rash—Doxorubicin—thyroid cancer	0.000245	0.000648	CcSEcCtD
Eprosartan—Dermatitis—Doxorubicin—thyroid cancer	0.000245	0.000648	CcSEcCtD
Eprosartan—Headache—Doxorubicin—thyroid cancer	0.000243	0.000644	CcSEcCtD
Eprosartan—Nausea—Doxorubicin—thyroid cancer	0.000231	0.000611	CcSEcCtD
